Taking aim at disease

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus
ORNL radioisotope manufacturing coordinator Jillene Sennon-Greene places a shipment vial of actinium-225 inside the dose calibrator to confirm its activity is within customer specifications. (Photo: Carlos Jones/ORNL, DOE)

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.

That tiny amount of the radioisotope was purchased by the hospital for use in cancer studies. And it heralded a new peacetime mission for ORNL, built just a few years earlier for the production of plutonium from uranium for the Manhattan Project.

To continue reading, log in or create a free account!

Related Articles

Taking a train to Texas

As part of its DUF6 conversion program, the DOE is shipping converted depleted uranium oxide to WCS for disposal.

April 11, 2024, 7:01AMRadwaste Solutions

Last year in late August, 120 storage cylinders of depleted uranium oxide (DUOx) safely arrived by rail in West Texas, having been shipped from the Department of Energy’s Portsmouth Site in...